81 related articles for article (PubMed ID: 26125077)
1. New Strategies to Address Critical Challenges.
Holbrook S
J Nucl Med Technol; 2014 Jun; 42(2):10A. PubMed ID: 26125077
[No Abstract] [Full Text] [Related]
2. Quality and value of nuclear medicine and molecular imaging: the impact of health-care reform.
Mitchell KR; Bunning SK
J Nucl Med Technol; 2013 Mar; 41(1):3-8. PubMed ID: 23463864
[No Abstract] [Full Text] [Related]
3. Advocating for appropriate and adequate reimbursement.
Dillehay G
J Nucl Med; 2013 Sep; 54(9):20N. PubMed ID: 24003172
[No Abstract] [Full Text] [Related]
4. Breaking an unhelpful circle, where innovation and regularia delay clinical practice for patient benefit.
Ell P; Carrio I; Chiti A
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1397-1398. PubMed ID: 30944948
[No Abstract] [Full Text] [Related]
5. SNMMI Leadership Update: FDA Approval of Imaging Agents: An Exciting Investment in Nuclear Medicine.
Schwarz SW
J Nucl Med; 2017 Jan; 58(1):20N. PubMed ID: 28062714
[No Abstract] [Full Text] [Related]
6. What is new and/or changing for reimbursement in 2006?
Merlino DA
J Nucl Med Technol; 2005 Dec; 33(4):245-6. PubMed ID: 16322127
[No Abstract] [Full Text] [Related]
7. PET/MR imaging consensus paper: a joint paper by the Society of Nuclear Medicine and Molecular Imaging Technologist Section and the Section for Magnetic Resonance Technologists.
Gilmore CD; Comeau CR; Alessi AM; Blaine M; El Fakhri GN; Hunt JK; Jordan DW; King BJ; Sicignano AJ; Stanley CT; Timpe JT; Wenzel-Lamb N
J Nucl Med Technol; 2013 Jun; 41(2):108-13. PubMed ID: 23633561
[No Abstract] [Full Text] [Related]
8. [Costing nuclear medicine diagnostic procedures].
Markou P
Hell J Nucl Med; 2005; 8(1):27-8. PubMed ID: 15886748
[TBL] [Abstract][Full Text] [Related]
9. Nuclear medicine innovations help (drive) healthcare (benefits).
Hacker M; Beyer T; Baum RP; Kalemis A; Lammertsma AA; Lewington V; Talbot JN; Verzijlbergen F
Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):173-5. PubMed ID: 25416634
[No Abstract] [Full Text] [Related]
10. Will the nuclear medicine industry survive?
Vermeeren PC
J Nucl Med; 1995 Jan; 36(1):17N-18N. PubMed ID: 7799072
[No Abstract] [Full Text] [Related]
11. In an era of tough choices, what is your comfort level?
DePuey EG
J Nucl Med; 1993 Oct; 34(10):1829-31. PubMed ID: 8280253
[No Abstract] [Full Text] [Related]
12. Nuclear medicine at a crossroads.
Schelbert HR
J Nucl Med; 2011 Dec; 52 Suppl 2():10S-5S. PubMed ID: 22144548
[TBL] [Abstract][Full Text] [Related]
13. Nuclear medicine and health care reform.
Miller L
J Nucl Med; 1993 Nov; 34(11):32N-34N. PubMed ID: 8229259
[No Abstract] [Full Text] [Related]
14. The opportunities and challenges posed by the rapid growth of diagnostic imaging.
Rothenberg BM; Korn A
J Am Coll Radiol; 2005 May; 2(5):407-10. PubMed ID: 17411844
[TBL] [Abstract][Full Text] [Related]
15. [Cost-effectiveness of radiopharmaceuticals in the hospital].
Fotopoulos A
Hell J Nucl Med; 2005; 8(1):29. PubMed ID: 15886749
[TBL] [Abstract][Full Text] [Related]
16. CPT code recommendations for nuclear medicine therapy.
McKusick KA; Wilson M
J Nucl Med; 2002 Jul; 43(7):27N-28N. PubMed ID: 12109487
[No Abstract] [Full Text] [Related]
17. Coding in nuclear medicine, from examination to tariff: an iterative process.
Hall M; Beadsmoore C; Allen S; Abbotts N
Nucl Med Commun; 2016 Nov; 37(11):1113-5. PubMed ID: 27603911
[No Abstract] [Full Text] [Related]
18. Changes and challenges in health insurance.
Tankersley RL
Va Dent J; 1992; 69(1):12-5. PubMed ID: 1621419
[No Abstract] [Full Text] [Related]
19. [Reimbursement for alternative medical treatment in the Netherlands, incomprehensible].
van den Hoogen MW; Popa C; Elving LD; van der Meer JW
Ned Tijdschr Geneeskd; 2012; 156(6):A4227. PubMed ID: 22316681
[TBL] [Abstract][Full Text] [Related]
20. Radiopharmaceutical therapy.
Parman CC
J Oncol Manag; 2002; 11(4):6-7. PubMed ID: 12182287
[No Abstract] [Full Text] [Related]
[Next] [New Search]
